Project RESTORE Team

Project RESTORE exists within one of the premiere medical research institutions and hospitals in the world, Johns Hopkins Medicine, an institution with an unequalled commitment to biomedical research. Project RESTORE has been so successful because of the expertise, resources and commitment at Johns Hopkins. It is a collaborative effort between our multiple sclerosis  and transverse myelitis centers neurologists:

Birnbaum, Julius
Assistant Professor of Medicine, Division of Rheumatology
Assistant Professor of Neurology

Calabresi, Peter
Professor of Neurology
Director, The Johns Hopkins Multiple Sclerosis Center
Director, Division of Neuroimmunology

Kaplin, Adam
Assistant Professor of Psychiatry

McArthur, Justin
Director, Department of Neurology
Professor of Neurology, Pathology, Epidemiology and Medicine
Neurologist-in-Chief

Pardo-Villamizar, Carlos
Associate Professor of Neurology and Pathology

Venkatesan, Arun
Assistant Professor of Neurology

As we embark upon the next five years of the Johns Hopkins Project RESTORE, we want to reflect on the accomplishments and advances made over the first five years by our team.

• In 2010, for the 20th year in a row, U.S. News and World Report recognized The Johns Hopkins Hospital as the “Best of the Best” in its annual rankings;
• The Johns Hopkins School of Medicine is the #1 recipient of National Institutes of Health research funding in the country;
• In 2010, Johns Hopkins Neurology was ranked the #1 neurology program in the country by U.S. News and World Report ;
• Fourteen Nobel prizes in Medicine have been awarded to Johns Hopkins-trained scientists;
• Johns Hopkins has four of the twenty most cited neuroscientists nationally; no other institution has more than one;
• Johns Hopkins Medicine is a $3.5 billion enterprise with over 3,100 faculty members, 696 house staff trainees, 970 fellows, ad 22,000 staff and nearly 1,650 post-doctoral fellows;
• More than 1.9 million patients come to Johns Hopkins each year from around the world for state-of-the-art and experimental therapies.